Table 3 The resistance rates of MDR-AB to 14 antimicrobial agents in the years 2013 to 2018 (%)
Antibiotics | Total | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|
Imipenem | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Meropenem | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Ceftazidime | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Ceftriaxone | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Gentamicin | 98.2 | 100 | 100 | 96 | 100 | 93.8 | 100 |
Tobramycin | 85.2 | 100 | 93.3 | 84 | 92 | 87.5 | 53.3 |
Ciprofloxacin | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Levofloxacin | 94.4 | 83.3 | 100 | 96 | 92 | 93.8 | 100 |
Ampicillin/sulbactam | 99.1 | 100 | 100 | 100 | 100 | 93.8 | 100 |
Trimethoprim/sulfamethoxazole | 76.7 | 100 | 13.3 | 56 | 52 | 93.8 | 100 |
Piperacillin/tazobactam | 99.1 | 100 | 100 | 100 | 100 | 93.8 | 100 |
Cefperazone/sulbactam | 77.8 | 83.3 | 66.7 | 80 | 80 | 75 | 80 |
Tigecycline | 6.5 | 8.3 | 6.7 | 4 | 8 | 0 | 13.3 |
Polymyxin B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |